217 related articles for article (PubMed ID: 11812719)
1. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
[TBL] [Abstract][Full Text] [Related]
2. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
3. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
Wichmann S; Færk G; Bundgaard JR; Gätke MR
Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
[TBL] [Abstract][Full Text] [Related]
4. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
[TBL] [Abstract][Full Text] [Related]
5. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
[TBL] [Abstract][Full Text] [Related]
6. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
[TBL] [Abstract][Full Text] [Related]
7. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Mintjens N; Brummans R; Soetens F; Claes KBM; Vanlinthout LE
Acta Anaesthesiol Scand; 2021 Feb; 65(2):182-187. PubMed ID: 33010031
[TBL] [Abstract][Full Text] [Related]
8. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.
Levano S; Ginz H; Siegemund M; Filipovic M; Voronkov E; Urwyler A; Girard T
Anesthesiology; 2005 Mar; 102(3):531-5. PubMed ID: 15731589
[TBL] [Abstract][Full Text] [Related]
9. Prolonged paralysis related to mivacurium: a case study.
Kendrick K
J Perianesth Nurs; 2005 Feb; 20(1):7-12. PubMed ID: 15688329
[TBL] [Abstract][Full Text] [Related]
10. Mivacurium compared with succinylcholine in children with liver disease.
Green DW; Fisher M; Sockalingham I
Br J Anaesth; 1998 Sep; 81(3):463-5. PubMed ID: 9861140
[TBL] [Abstract][Full Text] [Related]
11. [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
Lang C; Lukasewitz P; Wulf H; Geldner G
Anaesthesist; 2002 Feb; 51(2):134-41. PubMed ID: 11963306
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
13. [Residual relaxant block due to pseudocholinesterase deficiency - First manifestation in an elderly patient].
Zoller M; Walther S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Jan; 49(1):8-11. PubMed ID: 24446003
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous pseudocholinesterase deficiency: a case report and review of the literature.
Maiorana A; Roach RB
J Oral Maxillofac Surg; 2003 Jul; 61(7):845-7. PubMed ID: 12856264
[No Abstract] [Full Text] [Related]
15. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
[TBL] [Abstract][Full Text] [Related]
16. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.
Rosenberg MK; Lebenbom-Mansour M
Anesth Analg; 1997 Feb; 84(2):457-60. PubMed ID: 9024049
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
[TBL] [Abstract][Full Text] [Related]
18. [Cholinesterases].
Lejus C; Blanloeil Y; Burnat P; Souron R
Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency].
Kaiser E; Petit D; Quinot JF; Suppini A; Sallaberry M
Ann Fr Anesth Reanim; 1995; 14(6):505-7. PubMed ID: 8745975
[TBL] [Abstract][Full Text] [Related]
20. [Conditions of intubation and neuromuscular block induced by mivacurium: comparison with succinylcholine].
Fuentes de Frutos AL; Muriel Villoria C; Romo Cortina MT
Rev Esp Anestesiol Reanim; 1999 Apr; 46(4):143-8. PubMed ID: 10365610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
